Pharvaris PHVS
NASDAQ PHVS
$35.25 -0.41 (-1.15%)
As of: Sep 4, 2026 · 3:59 PM EDT

Pharvaris (PHVS) Share-based Compensation (2020 - 2026)

Pharvaris' (PHVS) quarterly Share-based Compensation came in at $5.7 million in Q1 2026, up 32.07% YoY from $4.3 million in Q1 2025, and up 8.56% on a QoQ basis from $5.3 million in Q4 2025.

Analysis

Pharvaris (PHVS) Share-based Compensation (2020 - 2026) Analysis & Trends

Pharvaris (PHVS) has 7 years of Share-based Compensation data on file, last reported at $5.7 million in Q1 2026.

  • Quarterly Share-based Compensation rose 32.07% year-over-year to $5.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23.0 million (up 19.05% YoY) and the FY2025 annual result came in at $21.5 million, up 22.69% from the prior year.
  • Share-based Compensation grew to $5.7 million in Q1 2026, from $5.3 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $5771.1 billion in Q2 2023 to a low of -$5769.3 billion in Q3 2023.
  • A 5-year average of $108.1 million and a median of $4.2 million in 2024 frame the typical range for Share-based Compensation.
  • The widest YoY moves for Share-based Compensation: up 172087079.47% in 2023, down 187987220.43% in 2023.
  • Tracing PHVS's Share-based Compensation over 5 years: stood at $3.3 million in 2022, then dropped by 18.73% to $2.7 million in 2023, then jumped by 93.92% to $5.2 million in 2024, then gained by 2.16% to $5.3 million in 2025, then advanced by 8.56% to $5.7 million in 2026.
  • The last three Share-based Compensation figures came in at $5.7 million (Q1 2026), $5.3 million (Q4 2025), and $5.7 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 108.10 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 243.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 120.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 277.20 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 137.41 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 86.63 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 41.25 Mn
10 Pharvaris 2.10 Bn 1.73 Bn 85,072.10 7.71 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.71 Mn
Mar 31, 2026 5.73 Mn
Dec 31, 2025 5.28 Mn
Sep 30, 2025 5.71 Mn
Jun 30, 2025 6.22 Mn
Mar 31, 2025 4.34 Mn
Dec 31, 2024 5.17 Mn
Sep 30, 2024 -6,905.92 Bn
Jun 30, 2024 6,771.79 Bn
Mar 31, 2024 2.61 Mn
Dec 31, 2023 2.67 Mn
Sep 30, 2023 -5,769.32 Bn
Jun 30, 2023 5,771.09 Bn
Mar 31, 2023 2.77 Mn
Dec 31, 2022 3.28 Mn
Sep 30, 2022 -5,131.88 Bn
Jun 30, 2022 5,431.08 Bn
Mar 31, 2022 2.19 Mn
Dec 31, 2021 2.28 Mn
Sep 30, 2021 2.76 Mn